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Background
The membrane-proximal external region (MPER) of HIV-
1 gp41, which is thought to be involved in the viral fusion
process, is an important target for an HIV vaccine. Two
broadly neutralizing monoclonal antibodies, 2F5 and
4E10, bind to adjacent linear epitopes in the gp41 MPER.
However, attempts to design immunogens that elicit a
neutralizing antibody response against this region have
had limited success.
Methods
We inserted the gp41-derived epitope sequences into the
envelope glycoprotein G of Vesicular Stomatitis Virus
(VSV). VSV G forms homotrimeric spikes on the viral sur-
face, mediates binding of the virus to cells and promotes
fusion of the viral and cellular membranes. The mem-
brane-proximal ''stem'' region of VSV G, which plays a
role in VSV fusion, shares sequence similarities with the
HIV-1 gp41 MPER. We created chimeric polypeptides by
substituting residues in the G stem with the 2F5 and 4E10
epitopes, generated pseudotyped lentiviruses or rescued
VSV with the mutant envelope proteins incorporated, and
tested the function and antibody reactivity of the recom-
binant viruses.
Results
VSV-G-2F5 and VSV-G-4E10 formed trimers and were
transported to the cell surface, where they were recognized
by the 2F5 and 4E10 monoclonal antibodies, respectively.
Pseudotyped lentiviruses or recombinant VSV containing
G-2F5 or G-4E10 on the viral surface were infectious, and
the mutant viruses were neutralized by the 2F5 or 4E10
monoclonal antibodies. We are currently determining if
the recombinant viruses are capable of eliciting a neutral-
izing antibody response in a small animal model.
Conclusion
These results suggest that the 2F5 and 4E10 epitopes
inserted into the VSV G stem region, which is likely to be
the functional equivalent of the HIV-1 gp41 MPER, adopt
a conformation similar to the one in their native context
in gp41. Our approach represents a novel strategy to
develop a vaccine that induces a humoral immune
response against HIV.
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